Highlights Eurofins Scientific SE

Equities

ERF

FR0014000MR3

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 16:55:00 05/12/2025 GMT			After hours 20:59:59
58.82 ^EUR	-0.37%		58.77	-0.09%

12-02	Eurofins Medical Device Services North America Launches First GMP Pfas Screening and Testing Solutions for Medical Devices	CI
11-05	CAC40 Attempts to Avoid a Seventh Consecutive Decline, Buoyed by Nasdaq Rebound

Highlights

Eurofins Medical Device Services North America Launches First GMP Pfas Screening and Testing Solutions for Medical Devices	12-02	CI
AlphaValue/Baader Europe Cuts Eurofins Scientific Rating, Price Target	10-23	MT
Berenberg Maintains Eurofins Scientific at Hold Amid Continued BioPharma Segment Headwinds	10-23	MT
Eurofins Scientific SE Reports Revenue Results for the Third Quarter and Nine Months Ended September 30, 2025	10-21	CI
Eurofins Shares Plunge After Disappointing Third Quarter Results	10-21	RE
Eurofins Reports 4% Organic Revenue Growth Over Nine Months	10-21
Eurofins 9m organic revenue growth at 4.0%	10-21	RE
Eurofins Scientific Finalizes Related Party-owned Sites Acquisition	09-03	MT
French and Benelux stocks-Factors to watch	07-30	RE
Wall Street's boring records	07-23
Eurofins: H1 EPS up over 18%	07-23
Eurofins Scientific SE Provides Earnings Guidance for Fiscal Year 2025 and for the Mid-Term to Fiscal Year 2027	07-23	CI
Eurofins Scientific SE Reports Earnings Results for the Half Year Ended June 30, 2025	07-23	CI
Eurofins H1 adj. ebitda eur 810 mln	07-23	RE
Eurofins Reports 7% Rise in H1 EBITDA, Confirms Financial Targets	07-23	RE
Tranche Update on Eurofins Scientific SE's Equity Buyback Plan announced on September 2, 2024.	07-22	CI
Tranche Update on Eurofins Scientific SE's Equity Buyback Plan announced on April 25, 2025.	07-22	CI
Eurofins Scientific SE acquired PLANTON GmbH from Michael Kleine and others.	05-19	CI
Ex-dividend day for final dividend	04-27	FA
Eurofins Scientific SE commences an Equity Buyback for 10% of its issued share capital, under the authorization approved on April 24, 2025.	04-25	CI
Eurofins Scientific To Buy Back Max. 4.5% Of Its Shares	04-25	RE
Eurofins Scientific SE 's Equity Buyback announced on September 2, 2024 has expired with 10,577,475 shares, representing 5.69% for ?463.01 million.	04-23	CI
Eurofins: Q1 sales up nearly 7%	04-23
Eurofins Q1 Revenues At EUR 1.77 Bln	04-23	RE
Eurofins Scientific SE Proposes Annual Dividend, Payable on April 30, 2025	04-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

EUROFINS SCIENTIFIC : Resetting valuation and target price following transfer of coverage

October 22, 2025 at 08:56 am